Optiscan Imaging Ltd (OIL) fair value: what the stock is really worth
As of Oct 5, 2026: fair value of Optiscan Imaging Ltd A$0.02, price A$0.17, upside -90.0%, quality 26 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range A$0.0720 – A$0.2744 · fair‑value band A$0.0085 – A$0.0170 · the A$0.1700 price screens above the A$0.0170 fair value. Dashed = 300-day average. As of Oct 4, 2026.
Follow Optiscan Imaging in your weekly email
Every Wednesday you see whether Optiscan Imaging is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States.
Show more
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows; InVivage, an intra-oral endomicroscope for oral imaging solutions; and ViewnVivo, a miniaturized in vivo imaging device for life sciences, pre-clinical and translational research. The company also provides InSpecta, a novel digital microscopic imaging device for veterinary medicine. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Stock analysis
Optiscan Imaging Ltd (OIL) currently trades at A$0.1700, while our model-based Fair Value estimate is A$0.0170, 90.0% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: A$0.0085 (bear) to A$0.0170 (bull), the price of A$0.1700 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Technology sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Optiscan Imaging Ltd reported revenue of A$449K in FY2026 versus A$1.0M in FY2022, a compound −18.4%/yr. Reported net income was −A$7.0M in FY2026.
Key figures
Market cap A$178M (≈ $123M) · P/S ratio 47.7 · EPS (TTM) A$−0.0100 · Net margin −193% · Return on equity −52.4% · Return on assets (EBIT) −68.4% · Operating margin −183% · Revenue growth (YoY) +125%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 13% below its 52-week high and 110% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −41% fair-value upside, at −90%, OIL screens richer than that median.
Fair Value models
Bear A$0.0085Fair Value A$0.0170Bull A$0.0170
Price A$0.1700 · Upside -90.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−88.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−35.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.8%
Start year 2021 (pandemic). Over 10 years: +3.8% a year
Revenue growth 26 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−418.5% (2021) → −2,362.7% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 160 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Optiscan Imaging Ltd (OIL) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of A$0.0170 versus a price of A$0.1700, about −90% upside (overvalued).
What is the fair value of OIL?
Our model-based fair value for Optiscan Imaging Ltd is A$0.0170 (as of Oct 4, 2026), built from audited fundamentals. The current price: A$0.1700.
What is the quality score of OIL?
Optiscan Imaging Ltd has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Optiscan Imaging Ltd (OIL)?
Our model-based price target is the fair value of A$0.0170 (as of Oct 4, 2026) from 1 valuation models. Cautious scenario A$0.0085, optimistic scenario A$0.0170. It is a calculation from audited fundamentals, not an analyst target.
What is the Optiscan Imaging Ltd stock forecast for 2026?
Our models put fair value at A$0.0170, about −90% upside versus a price of A$0.1700 (overvalued). Cautious scenario A$0.0085, optimistic scenario A$0.0170. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Optiscan Imaging Ltd (OIL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Optiscan Imaging Ltd it is A$0.0170 per share (as of Oct 4, 2026), against a price of A$0.1700. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Optiscan Imaging Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, OIL trades above its calculated fair value: price A$0.1700, fair value A$0.0170, a gap of about −90% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OIL?
No. The price is what the market pays today (A$0.1700); the fair value is what the company's own numbers justify (A$0.0170). For Optiscan Imaging Ltd the two are A$0.1530 per share apart. That gap is exactly why we show both numbers side by side.
How much is Optiscan Imaging Ltd worth?
The market values Optiscan Imaging Ltd at about A$178M (market capitalisation, as of Oct 4, 2026). Per share that is A$0.1700; our models calculate a fair value of A$0.0170 per share.
What do the bullish and bearish scenarios say about OIL?
Our models span a range for Optiscan Imaging Ltd: cautious scenario A$0.0085, base A$0.0170, optimistic A$0.0170 per share (as of Oct 4, 2026, price A$0.1700). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of OIL?
The PEG ratio of Optiscan Imaging Ltd is 2.41 (P/E divided by earnings growth, as of Oct 4, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Optiscan Imaging Ltd (OIL)?
Balance-sheet figures for Optiscan Imaging Ltd (as of Oct 4, 2026): return on equity −52.4%, debt of 0.03 per unit of equity. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is OIL from its 52-week high?
Optiscan Imaging Ltd trades at A$0.1700, about 13% below its 52-week high of A$0.1950 and 110% above the low of A$0.0810 (as of Oct 5, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0170 is for.
Which stocks are comparable to Optiscan Imaging Ltd?
From the same area (Technology) we also value Keysight Technologies, Inc, Coherent Corp, Garmin Ltd, Chroma ATE Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Optiscan Imaging Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price A$0.1700, calculated fair value A$0.0170 (−90%), Quality Score 26/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OIL calculated?
We run Optiscan Imaging Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.0170, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Optiscan Imaging Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Optiscan Imaging Ltd (OIL)?
The closing price on Oct 5, 2026 was A$0.1700. Our model-based fair value is A$0.0170, about −90% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Optiscan Imaging Ltd right now?
The price sits above even our optimistic bull case (A$0.0170). The favourable scenario is already priced in. Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (A$0.0085 to A$0.0170) leaves room in how you read the outcome.
Key figures of Optiscan Imaging Ltd
How large is the market capitalisation of Optiscan Imaging Ltd (OIL)?
The market capitalisation of Optiscan Imaging Ltd is A$178M (≈ $123M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Optiscan Imaging Ltd (OIL)?
The price-to-sales ratio of Optiscan Imaging Ltd is 47.7 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Optiscan Imaging Ltd (OIL)?
Earnings per share at Optiscan Imaging Ltd are A$−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Optiscan Imaging Ltd (OIL)?
The net margin of Optiscan Imaging Ltd is −193% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Optiscan Imaging Ltd (OIL)?
The return on equity (ROE) of Optiscan Imaging Ltd is −52.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Optiscan Imaging Ltd (OIL)?
On an EBIT basis the return on assets of Optiscan Imaging Ltd is −68.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Optiscan Imaging Ltd (OIL)?
The operating margin of Optiscan Imaging Ltd is −183% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Optiscan Imaging Ltd (OIL)?
Revenue at Optiscan Imaging Ltd is growing +125% versus a year earlier (3y avg −35.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Optiscan Imaging Ltd (OIL) generate?
The free cash flow of Optiscan Imaging Ltd is −A$7.4M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Optiscan Imaging Ltd (OIL) hold?
Optiscan Imaging Ltd holds more cash than debt, A$13.0M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Optiscan Imaging Ltd in the live analysis
One click puts Optiscan Imaging Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
